Fair Value Calculator Fair Value Calculator
EN DE

So-Young International Inc (SY) Fair Value & Analysis

Healthcare · US · Market cap $157M

SY So-Young International Inc logo So-Young International Inc SY · US
Price$1.68
Fair Value$0.3000
Upside-82.1%
Quality28/100
Watch So-Young International Inc for free, get notified when fair value or trend changes. Watch for free
Evidence: Low Range $0.2000 – $0.3700

Fair value as of: Jul 19, 2026

From 3 valuation models · updated today

Fair value updated Jul 19, 2026, revised from $9.44 to $0.3000 (−96.8%) since Jun 24, 2026. Share price +8.7% over the past month.

Price vs Fair Value (12 months)

$5.87 $1.32 Fair Value $0.3000 Jul 2025 Jul 2026

12‑month range $1.32 – $5.87 · fair‑value band $0.2000 – $0.3700 · the $1.68 price screens above the $0.3000 fair value. As of Jul 19, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

So-Young International Inc (SY) currently trades at $1.68, while our model-based Fair Value estimate is $0.3000, implying the stock looks roughly 82.1% overvalued today. We read business quality at 28/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).

Over the trailing twelve months, So-Young International Inc generated revenue of $1.7B at a net margin of -15.6%. Revenue grew 45.6% year over year. It earns a return on equity of -15.0%. The balance sheet holds a net cash position of $183M. Fundamentals as of Jul 19, 2026

Our scenario range runs from $0.2000 (bear case) to $0.3700 (bull case); at $1.68, the current price sits above that range. The share trades about 73% below its 52-week high and 31% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -33% fair-value upside, at -82%, SY screens richer than that median.

Key figures & financial health

Revenue (TTM) $1.7B
Revenue growth (YoY) +45.6%
Net margin -15.6%
Return on equity -15.0%
Free cash flow −$302M FY2025
Operating margin -13.4%
More key figures
EPS (TTM) $-0.3800
EPS growth (YoY) +7.5%
Net cash $183M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 19, 2026. TTM = trailing twelve months.

About the company

So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users access to medical aesthetic knowledge, community support and reservation options for treatment with medical professionals, and medical aesthetic institutions; Weixin mini program to explore treatment options, check prices, schedule appointments, participate in online consultations, and track follow-ups; and medical aesthetic community content through its website soyoung.com. Its aesthetic centers offer non-invasive to minimally invasive procedures, including device-based options, such as thread lifts, intense pulsed light, ultrasound facelifts, picosecond lasers, and body contouring treatments, as well as injectable treatments, including skin boosters, hyaluronic acid-based products, botox, and type I and type III collagen. In addition, the company engages in the research and development, production, …

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

So-Young International Inc reported revenue of $1.5B in FY2025 versus $1.7B in FY2021, a compound −3.3%/yr. Reported net income was −$236M in FY2025.

Revenue −3.3%/yr
FY21 $1.7B
FY22 $1.3B
FY23 $1.5B
FY24 $1.5B
FY25 $1.5B
Net income
FY21 −$8.4M
FY22 −$65.6M
FY23 $21.3M
FY24 −$590M
FY25 −$236M

Is SY fairly valued? → Check now

📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog, it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "So-Young International Inc Fair Value". https://www.fairvalue-calculator.com/stock/SY

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jul 19, 2026).

Stock Price Fair Value vs Fair Value
Veeva Systems Inc VEEV $172.61 $104.16 -40%
Pro Medicus Limited PME A$161.58 A$33.82 -79%
BrightSpring Health Services, Inc BTSG $60.59 $23.87 -61%
Tempus AI, Inc TEM $48.61 $12.67 -74%
HealthEquity, Inc HQY $84.61 $79.57 -6%
Hinge Health, Inc HNGE $62.06 $78.43 +26%
M3, Inc MTHRY $5.03 $7.44 +48%
10x Genomics, Inc TXG $31.04 $20.68 -33%
Waystar Holding WAY $18.80 $14.86 -21%
Ping An Healthcare and Technology Company PANHF $0.9000 $0.5700 -37%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is So-Young International Inc (SY) undervalued?
As of Jul 19, 2026, our model estimates a fair value of $0.3000 versus a price of $1.68, about −82% (overvalued). Model-based estimate, not financial advice.
What is the fair value of SY?
Our model-based fair value for So-Young International Inc is $0.3000 (as of Jul 19, 2026), built from audited fundamentals. The current price is $1.68.
What is the quality score of SY?
So-Young International Inc has a Quality Score of 28/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of So-Young International Inc (SY)?
So-Young International Inc reported trailing-twelve-month revenue of about $1.7B (latest available figure, as of Jul 19, 2026).
What is the net profit margin of SY?
The net profit margin of So-Young International Inc is about -15.6%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Unlock the full So-Young International Inc analysis, and try Pro free

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.